Clinical trials
Phase 3 Multiple Myeloma trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 4 |
| Pfizer | 4 |
| Amgen | 2 |
| Bristol-Myers Squibb | 1 |
| European Myeloma Network B.V. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Janssen Research & Development, LLC | 1 |
| Janssen-Cilag International NV | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Nordic Myeloma Study Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 19 |
| Recurrence | 6 |
| Neoplasms, Plasma Cell | 4 |
| Blast Crisis | 1 |
| Bone Marrow Neoplasms | 1 |
| Burkitt Lymphoma | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Fever | 1 |
| Hematologic Diseases | 1 |
| Hodgkin Disease | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.